Duke Street Bio announces first patient dosed in Phase I trial with DSB2455, a next deneration PARP1 selective inhibitor for the treatment of solid tumours
December 3, 2024
December 3, 2024
September 26, 2024
September 24, 2024
May 15, 2024
May 14, 2024
May 8, 2024
May 6, 2024
February 21, 2024
February 20, 2024
April 24, 2026
Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer. With over 25 years of industry leadership, Kongsbak will lead the...
April 20, 2026
AxisOne combines artificial intelligence with milestone-based delivery to accelerate lab selection, tighten research execution, and close the accounta...
April 20, 2026
Membership deepens ENPICOM's commitment to advance AI and autonomous agent infrastructure for life sciences R&D ENPICOM, an innovative bioinformat...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225